Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats

Journal of Periodontology

Volumn 73, Issue 9, 2002, Pages 1030-1036

  Holzhausen, Marinella ^a   Rossa, Carlos ^a   Marcantonio Jr , Elcio ^a   Nassar, Patría O ^a   Spolidório, Denise M P ^a   Spolidório, Luis C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alveolar bone loss prevention and control; Animal studies; Cyclooxygenase inhibitors; Periodontitis prevention and control

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; SODIUM CHLORIDE;

ALVEOLAR BONE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; CONTROLLED STUDY; DIGITAL RADIOGRAPHY; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; GINGIVA; LEUKOCYTE COUNT; MALE; MOLAR TOOTH; NONHUMAN; PERIODONTITIS; RANDOMIZATION; RAT; RAT STRAIN; TOOTH ROOT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE PROGRESSION; ISOENZYMES; LEUKOCYTE COUNT; LIGATION; MALE; PERIODONTITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 0036738816     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.9.1030     Document Type: Article

References (40)

1. Drisko C. Non-surgical pocket therapy: Pharmacotherapeutics. Ann Periodontol 1996;1:491-566.
2. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
3. Salvi GE, Williams RC, Offenbacher S. Nonsteroidal anti-inflammatory drugs as adjuncts in the management of periodontal diseases and peri-implantitis. Curr Opin Periodontol 1997;4:51-58.
4. Waite IM, Saxton CA, Young A, Wagg BJ, Corbett M. The periodontal status of subjects receiving non-steroidal anti-inflammatory drugs. J Periodont Res 1981;16:100-108.
5. Feldman RS, Szeto B, Chauncey HH, Goldhaber P. Non-steroid anti-inflammatory drugs in the reduction of human alveolar bone loss. J Clin Periodontol 1983;10: 131-136.
6. Jeffcoat MK, Page R, Reddy M, et al. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodont Res 1991;26:415-421.
7. Heasman PA, Benn DK, Kelly PJ, Seymour RA, Aitiken D. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Periodontol 1993;20:457-464.
8. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993;20:635-640.
9. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995;66:329-338.
10. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase (COX)-2 in inflammation and pain. Proc Natl Acad Sci (USA) 1994;91:12013-12017.
11. Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3 -(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-1365.
12. Pirson Y, van Ypersele de Strihou C. Renal side effects of nonsteroidal anti-inflammatory drugs: Clinical relevance. Am J Kidney Dis 1986;8:337-344.
13. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs. N Engl J Med 1992;327:749-754.
14. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci (USA) 1994;91:3228-3232.
15. Morton RS, Dongari-Bagtzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J Periodontol 2001;72:461-469.
16. Bezerra MM, Lima V, Alencar VBM, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000; 71:1009-1014.
17. Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307-314.
18. Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib. A selective cyclooxygenase-2 inhibitor. Clin Pharmacokinet 2000;38:225-242.
19. Lanza FL, Rack MF, Callison DA, et al. A pilot endoscopic study of the gastroduodenal effects of SC-58635, a novel COX-2 selective inhibitor. Gastroenterol 1997; 112(Suppl. 4):A194.
20. Geis GS, Stead H, Morant SV, Naudin R, Hubbard RC. Endoscopic and tolerability results from a study of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis. Rheumatol Eur 1998;27(Suppl. 1): 118.
21. Simon L S, Lanza FL, Lipsky PE, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor. Arthritis Rheum 1998;41:1591-1601.
22. Sallay K, Sanavi F, Ring I, Pham P, Behling UH, Nowotny A. Alveolar bone destruction in the immunosuppressed rat. J Periodont Res 1982;17:263-274.
23. Nociti FH Jr., Nogueira-Filho GR, Primo MT, et al. The influence of nicotine on the bone loss rate in ligature-induced periodontitis. A histometric study in rats. J Periodontol 2000;71:1460-1464.
24. Rose MJ, Woolf BK, Matuszewski BK. Determination of celecoxib in human plasma by high-performance liquid chromatography with column switching and ultraviolet absorbance detection. J Chromatogr B Biomed Sci Appl 2000;738:377-385.
25. Farris EJ, Griffith JQ. The Rat in Laboratory Investigation. New York: Hafner Publishing Co.; 1949:406-420.
26. Johnson IH. Effects of local irritation and dextran sulphate administration on the periodontium of the rat. J Periodont Res 1975;10:332-345.
27. Klausen B, Evans RT, Sfintescu C. Two complementary methods of assessing periodontal bone level in rats. Scand J Dent Res 1989;97:494-499.
28. Bissada NF, Schaffer EM, Lazarow A. Effect of alloxan diabetes and local irritating factors on the periodontal structures of the rat. Periodontics 1966;4:233-240.
29. Carranza FA Jr., Simes RJ, Mayo J, Cabrini R. Histometric evaluation of periodontal bone loss in rats. J Periodont Res 1971;6:65-72.
30. Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Pharmacol 1998;95:13313-13318.
31. Wallace JL, Chapman K, McKnight W. Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-airpouch inflammation. Br J Pharmacol 1999;126:1200-1204.
32. Jeffcoat MK, Kaplan ML, Goldhaber P, Williams RC. Nuclear medicine. An indicator of "active" alveolar bone loss in beagle dogs treated with a nonsteroidal anti-inflammatory drug. J Periodontol 1985;56:8-12.
33. Howell TH, Jeffcoat MK, Goldhaber P, et al. Inhibition of alveolar bone loss in beagles with the NSAID naproxen. J Periodont Res 1991;26:498-501.
34. Howell TH, Jeffcoat MK, Goldhaber P, et al. Inhibition of alveolar bone loss in beagles with the NSAID naproxen. J Periodont Res 1991;26:498-501.
35. Sidhagen B, Hamberg M, Fredholm B. Formation of 121-hydroxyeicosatetraenoic acid (12-HETE) by gingival tissue. J Dent Res 1982;61:761-763.
36. El Attar T, Lin H. Relative conversion of arachidonic acid through lipoxygenase and cyclooxygenase pathways by homogenates of diseased periodontal tissues. J Oral Pathol 1983;12:7-10.
37. El Attar T, Lin H, Killoy W, Vanderhoek J, Goodson J. Hydroxy fatty acids and prostaglandin formation in diseased human periodontal pocket tissue. J Periodont Res 1986;21:169-176.
38. Meghji S, Sandy JR, Scutt AM, Harvey W, Harris M. Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid. Prostaglandins 1988;36:139-149.
39. Gallwitz WE, Mundy GR, Lee CH, et al. 5-lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem 1993; 268:10087-10094.
40. Kornman KS, Blodgett RF, Brunsvold M, Holt SC. Effects of topical applications of meclofenamic acid and ibuprofen on bone loss, subgingival microbiota and gingival PMN response in the primate Macaca fascicularis. J Periodont Res 1990;25:300-307.